Cite
MLA Citation
Sanjay Popat et al.. “Brigatinib vs crizotinib in ALK TKI-naive ALK+ NSCLC: final results from ALTA-1L.” Lung cancer, vol. 165, n.d., pp. S27–S28. http://access.bl.uk/ark:/81055/vdc_100150604774.0x00004b
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sanjay Popat et al.. “Brigatinib vs crizotinib in ALK TKI-naive ALK+ NSCLC: final results from ALTA-1L.” Lung cancer, vol. 165, n.d., pp. S27–S28. http://access.bl.uk/ark:/81055/vdc_100150604774.0x00004b